Torrent Pharma Gets Approval to Acquire Controlling Stake in JB Chemicals

Torrent Pharmaceuticals, the flagship company of the Torrent Group, has received regulatory clearance to move ahead with its planned acquisition of JB Chemicals & Pharmaceuticals. The Competition Commission of South Africa approved the transaction on 22 September 2025, marking a key milestone in Torrent’s strategic expansion.

Strategic Expansion Move

The acquisition, set to be executed through a controlling stake purchase from global investment firm KKR, is expected to bolster Torrent Pharma’s presence across therapeutic segments and strengthen its international footprint. JB Chemicals, known for its diverse portfolio of branded formulations and specialty drugs, aligns with Torrent’s focus on expanding in high-growth therapeutic areas.

Regulatory Greenlight

Torrent Pharma confirmed the approval in an exchange filing dated September 23, 2025, noting: “...this is to inform you that the Competition Commission, South Africa, has granted its approval for the transaction on 22nd September, 2025.” This regulatory nod removes a major hurdle in the acquisition process and paves the way for further integration planning.